Academic literature on the topic 'Primary pharmaceutical manufacturing'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Primary pharmaceutical manufacturing.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Primary pharmaceutical manufacturing"
Sarin, Subhash C., Hanif D. Sherali, and Lingrui Liao. "Primary pharmaceutical manufacturing scheduling problem." IIE Transactions 46, no. 12 (2014): 1298–314. http://dx.doi.org/10.1080/0740817x.2014.882529.
Full textOuranidis, Andreas, Christina Davidopoulou, Reald-Konstantinos Tashi, and Kyriakos Kachrimanis. "Pharma 4.0 Continuous mRNA Drug Products Manufacturing." Pharmaceutics 13, no. 9 (2021): 1371. http://dx.doi.org/10.3390/pharmaceutics13091371.
Full textNgugi, Grace Wanjiru, and Esther Gitonga. "Generic Strategies and Performance of Pharmaceutical Manufacturing Companies in Nairobi County, Kenya." International Journal of Business Management, Entrepreneurship and Innovation 3, no. 1 (2021): 17–35. http://dx.doi.org/10.35942/jbmed.v3i1.157.
Full textPrabhakar V S, Beula Evangeline C, Aravindhanathan V, Sruthi N, and Gowthamarajan K. "Regulatory Comparative Quality Systems of India and USA and its Significance in Pharmaceutical Industry Facilities." International Journal of Research in Pharmaceutical Sciences 11, SPL4 (2020): 2457–62. http://dx.doi.org/10.26452/ijrps.v11ispl4.4498.
Full textAziza, Farida. "Comparison Review of Two Regulatory Agencies Regulation: Therapeutic Goods Administration (TGA) and the European Medicine Agency (EMA) in Relation to Good Manufacturing Practice (GMP) Guideline." Majalah Farmaseutik 17, no. 2 (2021): 243. http://dx.doi.org/10.22146/farmaseutik.v17i2.60237.
Full textElsafty, Ashraf, and Mohamed Osman. "The Impact of COVID-19 on the Efficiency of Packing Lines in Pharmaceutical Manufacturing Sites in Egypt." International Journal of Business and Management 16, no. 7 (2021): 57. http://dx.doi.org/10.5539/ijbm.v16n7p57.
Full textLatysheva, E. A., T. V. Latysheva, and I. A. Martynova. "Evaluation of efficacy and safety of intravenous immunoglobulin IG VENA in patients with primary antibody synthesis immunodeficiency." Russian Journal of Allergy 13, no. 1 (2016): 16–22. http://dx.doi.org/10.36691/rja364.
Full textBano, Gabriele, Riccardo De-Luca, Emanuele Tomba, Agnese Marcelli, Fabrizio Bezzo, and Massimiliano Barolo. "Primary Drying Optimization in Pharmaceutical Freeze-Drying: A Multivial Stochastic Modeling Framework." Industrial & Engineering Chemistry Research 59, no. 11 (2020): 5056–71. http://dx.doi.org/10.1021/acs.iecr.9b06402.
Full textShim, Hyunjin, and Hongkee Sah. "Qualification of Non-Halogenated Organic Solvents Applied to Microsphere Manufacturing Process." Pharmaceutics 12, no. 5 (2020): 425. http://dx.doi.org/10.3390/pharmaceutics12050425.
Full textOluwadare, Oreofe Praise, Omoniyi Joseph Ola-Olorun, and Billy Adegbola Oluwale. "Assessment of Total Quality Management Adoption Level in Pharmaceutical Manufacturing Companies in Southwestern Nigeria." International Journal of Engineering Research in Africa 43 (June 2019): 168–77. http://dx.doi.org/10.4028/www.scientific.net/jera.43.168.
Full textDissertations / Theses on the topic "Primary pharmaceutical manufacturing"
Yao, Liming. "Modeling, Analysis and Solution Approaches for Some Optimization Problems: High Multiplicity Asymmetric Traveling Salesman, Primary Pharmaceutical Manufacturing Scheduling, and Lot Streaming in an Assembly System." Diss., Virginia Tech, 2008. http://hdl.handle.net/10919/27961.
Full textBook chapters on the topic "Primary pharmaceutical manufacturing"
Lloyd, Steven M., and Ronald W. Wizimirski. "Flexible Containment for Primary Manufacturing/Bulk Operations." In Containment in the Pharmaceutical Industry. CRC Press, 2020. http://dx.doi.org/10.1201/9780429074943-9.
Full textMenezes, J. C., A. P. Ferreira, L. O. Rodrigues, L. P. Brás, and T. P. Alves. "Chemometrics Role within the PAT Context: Examples from Primary Pharmaceutical Manufacturing." In Comprehensive Chemometrics. Elsevier, 2009. http://dx.doi.org/10.1016/b978-044452701-1.00012-0.
Full text"„ , . large-scale production rate Scale-up ratio = — - n\ small-scale production rate Disperse system scale-up ratios may vary from 10 to 100 for laboratory to pilot-plant process translation and 10 to 200 for scaling from pilot-plant to commercial produc-tion. Actual production rates may vary considerably from expected production rates, since overall process efficiency is dependent on a wide range of factors. The process-ing of disperse systems, whether liquid-liquid or liquid-solid, is still relatively empiri-cal due to the substantial interfacial effects that predominate and control the relevant unit operations. Furthermore, unit operations may function in a rate-limiting manner as the scale of operation increases from the laboratory bench to the pilot plant to com-mercial production. Thus, although conventional wisdom suggests the necessity of scale-up studies, the appropriate approach is not necessarily initiated with miniaturized com-mercial processing systems [5]. The concept of scale-up has taken on a substantive regulatory aspect in more re-cent years with the issuance of Guidance 22-90 by the Food and Drug Administration's (FDA's) Office of Generic Drugs in September 1990 and the establishment of the Scale-Up and Post Approval Changes (SUPAC) Task Force by the FDA's Center for Drug Evaluation and Research. In May 1993, the American Association of Pharmaceutical Scientists, the Food and Drug Administration, and the United States Pharmacopeia cosponsored a workshop on the scale-up of liquid and semisolid disperse systems [6]. The primary finished product attribute to control during the scale-up of a disperse sys-tem, whether manufactured in identical, similar, or different equipment, is the degree of sameness of the finished product relative to previous lots. The consensus of the workshop committee was that four criteria be used to evaluate sameness: (1) adherence to raw material controls and specifications; (2) adherence to in-process controls; (3) adherence to finished product specifications; and (4) bioequivalence to previous lots. The aim of this chapter is to provide the formulator with an appreciation, on the one hand, of the complexity of the scale-up problem associated with disperse systems, and an awareness, on the other hand, that scale-up problems can be resolved, to a great extent, by drawing on the vast literature and experience of chemical engineering. In 1964, H. W. Fowler [7] initiated a series of progress reports in pharmaceutical engi-neering that appeared over time in the periodical Manufacturing Chemist. Fowler's ouevre was distinguished by his focus on fundamentals, i.e., on material properties and on operation and process mechanisms. His intention was "to look at the literature of chemical engineering and to discuss developments which are relevant to pharmacy." It is the present author's intention (in part, through this chapter on scale-up of disperse systems) to validate the interdisciplinary process that Fowler began more than 30 years." In Pharmaceutical Dosage Forms. CRC Press, 1998. http://dx.doi.org/10.1201/9781420000955-60.
Full textConference papers on the topic "Primary pharmaceutical manufacturing"
Farrell, Paul, and Philip R. LeGoy. "Using Plasma Pyrolysis Vitrification (PPV) to Enhance Incineration Waste Ash Reduction in Ireland." In 10th Annual North American Waste-to-Energy Conference. ASMEDC, 2002. http://dx.doi.org/10.1115/nawtec10-1028.
Full textSchoenitz, Martin, Annika Hohlen, Wolfgang Augustin, and Stephan Scholl. "In-Process Cleaning of a Micro Heat Exchanger With Ultrasound During the Continuous Crystallization of Solid Lipid Nanoparticles." In ASME 2014 12th International Conference on Nanochannels, Microchannels, and Minichannels collocated with the ASME 2014 4th Joint US-European Fluids Engineering Division Summer Meeting. American Society of Mechanical Engineers, 2014. http://dx.doi.org/10.1115/icnmm2014-21821.
Full text